Apple introduced the iPhone in 2007 and the App Store in 2008 as, arguably, an innovator.
Both businesses which they were able to operate free from regulation (for anti-competitive conduct) for 15 years.
In doing so, they became the most valuable company in the world, by market cap.
Whereas in 2007 they weren’t even among the top 30 in the U.S. alone).
So… it took lawmakers 15 years to regulate and open up access to these platforms a bit. This isn’t really different than pharmaceutical patents, which have a validity of 20 years in most countries (but, as drugs have to go through testing and approval before being able to be marketed, so translate to shorter exclusivity in the market). And exclusivity periods for approved drugs are shorter.
Do I believe that such a posteriori (but narrowly defined) regulation will prevent companies from innovating and marketing their innovations in the EU?
No.